Biology of Aβ Amyloid in Alzheimer's Disease

Biology of Aβ Amyloid in Alzheimer's Disease

Bibliographic Details
Main Authors:	Thomas Wisniewski, Jorge Ghiso, Blas Frangione
Format:	Article
Language:	English
Published:	Elsevier 1997-01-01
Series:	Neurobiology of Disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996197901479

Similar Items

Mitochondrial β-amyloid in Alzheimer's disease.
by: Borger, E, et al.
Published: (2011)

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
by: Allal Boutajangout, et al.
Published: (2019-03-01)

A review of β-amyloid neuroimaging in Alzheimer’s disease
by: Paul eAdlard, et al.
Published: (2014-10-01)

Folding simulation of amyloid β-peptide in alzheimer's disease.
by: Koh, Jessica Li Jian.
Published: (2010)

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
by: Chenghuan Song, et al.
Published: (2022-03-01)

β-amyloid oligomers in aging and Alzheimer's disease
by: Kathleen R. Zahs, et al.
Published: (2013-07-01)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
by: Lin Nan, et al.
Published: (2011-06-01)

Amyloid β Modification: A Key to the Sporadic Alzheimer's Disease?
by: Evgeny P. Barykin, et al.
Published: (2017-05-01)

β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
by: Botond Penke, et al.
Published: (2017-10-01)

Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.
by: Jia-Ying Chuang, et al.
Published: (2012-01-01)

Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
by: Satoshi Fujii, et al.
Published: (2015-12-01)

Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients
by: Ilayda Ozsan McMillan, et al.
Published: (2024-04-01)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
by: Young Chul Youn, et al.
Published: (2019-05-01)

The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
by: Han Ly, et al.
Published: (2021-01-01)

Lipid peroxidation and Alzheimer’s disease: Key role of Amyloid-β
by: Kontush Anatol
Published: (2006-01-01)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
by: Dong Eun Kim, et al.
Published: (2020-02-01)

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
by: Xingyu Zhang, et al.
Published: (2018-11-01)

A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.
by: Fang Wang, et al.
Published: (2011-01-01)

Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease
by: Lili Donner, et al.
Published: (2021-09-01)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
by: Francesca Mantile, et al.
Published: (2020-11-01)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
by: Anne-Cathrine S. Vogt, et al.
Published: (2023-02-01)

Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease
by: Marcos J. Guerrero-Muñoz, et al.
Published: (2014-11-01)

Amyloid-β Oligomers Unveil a Novel Primate Model of Sporadic Alzheimer’s Disease
by: Joseph eJebelli, et al.
Published: (2015-03-01)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
by: Wisniewski Thomas, et al.
Published: (2008-12-01)

An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
by: Anna Lord, et al.
Published: (2009-12-01)

N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology
by: Agueda Rostagno, et al.
Published: (2022-06-01)

Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
by: Victoria Campos-Peña, et al.
Published: (2022-10-01)

Molecular imaging agents for detection of β-amyloid plaques in Alzheimer’s disease
by: Letícia Quental, et al.
Published: (2013-11-01)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
by: Yara Mashal, et al.
Published: (2022-07-01)

Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer’s Disease
by: Cosmin Stefan Mocanu, et al.
Published: (2020-10-01)

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology
by: Maria Laura Giuffrida
Published: (2023-04-01)

Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer’s Disease
by: Mélissa Gentreau, et al.
Published: (2022-06-01)

The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
by: Lukas Busch, et al.
Published: (2022-10-01)

Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
by: Yun Zhang, et al.
Published: (2023-06-01)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
by: Adla Boumenir, et al.
Published: (2019-03-01)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
by: Yuan Cheng, et al.
Published: (2022-05-01)

Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
by: Yukti Vyas, et al.
Published: (2020-04-01)

Drugs and drug delivery systems targeting amyloid-β in Alzheimer's disease
by: Morgan Robinson, et al.
Published: (2015-07-01)

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease
by: Georg M Kerbler, et al.
Published: (2015-01-01)

The situations and strategies of amyloid⁃β⁃directed passive immunotherapy for Alzheimer's disease
by: Ya LI, et al.
Published: (2019-12-01)